NEW YORK, NY — As October marks Breast Cancer Awareness Month, the familiar landscape of pink ribbons often dominates public discourse. However, for a specific and vulnerable community, this month represents something more urgent and less celebrated: a fight for survival against a disease that, for many, is still misunderstood. On October 13, National Metastatic Breast Cancer Awareness Day, a global movement will literally shine a light on the crisis. More than 325 landmarks across 20 countries will glow in the signature teal, green, and pink of metastatic breast cancer (MBC) awareness, as the organization METAvivor leads the charge to transform a terminal diagnosis into a manageable, long-term condition.
The Reality of Stage 4: Defining the Crisis
Metastatic breast cancer, or Stage 4, occurs when cancer cells spread from the original tumor in the breast to distant organs, most commonly the bones, liver, lungs, or brain. It is critical to note that even when found in other organs, it remains breast cancer; it is not, for instance, lung or liver cancer.
For the thousands of individuals living with this diagnosis, the "awareness" narrative often pushed during October—which frequently focuses on early detection and the "survivor" mentality—can feel alienating. MBC is currently incurable. Some patients are diagnosed at Stage 4 from the outset, while others find themselves here months, years, or even decades after completing treatment for earlier-stage breast cancer.
Treatment for MBC is not a temporary regimen; it is a permanent, lifelong commitment. Even when medical scans show "no evidence of disease," it does not equate to a cure. Instead, it signifies that current therapies are successfully holding the cancer at bay. Because cancer is biologically adaptive, it frequently develops resistance to existing treatments, forcing patients into a cycle of constant testing, switching medications, and managing the side effects of chronic therapy.
The human cost is staggering. In the United States alone, an estimated 42,670 people are projected to lose their lives to breast cancer in 2026—a rate of approximately 117 deaths every single day.
Chronology of a Movement: From Personal Loss to Global Beacon
The #LightUpMBC campaign did not begin in a corporate boardroom; it started as a deeply personal tribute to a life cut short.
- 2017: The movement had its humble beginnings in Portsmouth, New Hampshire, with the illumination of the Memorial Bridge. It was sparked by Laura Inahara, who sought to honor her best friend, Jessica Moore, who had succumbed to MBC at the age of 36. Jessica’s singular wish was to see a local landmark lit in the colors of the cause.
- 2018–2025: What began as a local memorial quickly gained momentum. As patient advocates realized the power of visual solidarity, more cities began to participate. The campaign evolved from a single bridge into a worldwide phenomenon, capturing the attention of major global icons.
- 2026: This year marks the most significant expansion to date, with over 325 landmarks in all 50 U.S. states and 20 countries participating. From the iconic One World Trade Center in New York and the Willis Tower in Chicago to international sites like Niagara Falls and the Ness Bridge in Scotland, the "Light Up" initiative has become the primary fundraising engine for METAvivor’s research grants.
Supporting Data: Why Targeted Research Matters
METAvivor Research and Support, Inc. occupies a unique space in the oncology landscape. Unlike organizations that fund general breast cancer awareness or early detection, METAvivor exclusively allocates its resources to Stage 4 metastatic breast cancer research.
The necessity for this focus is backed by sobering statistics. While advancements in early-stage breast cancer treatment have been significant, the five-year survival rate for metastatic breast cancer remains far lower than that of early-stage disease. Research is the only path toward changing these numbers. METAvivor utilizes a rigorous, two-tier review process: every project they fund is vetted by both scientific experts and patient advocates. This ensures that the research is not only theoretically sound but also directly addresses the quality-of-life concerns and treatment efficacy gaps that matter most to the patient community.
To date, the #LightUpMBC campaign has raised over $2.7 million, directly funding innovative clinical trials and research projects that are currently underway. Every cent of net proceeds from the campaign and the accompanying live stream is funneled directly into these life-extending studies.
Official Responses and Perspectives
The leadership behind #LightUpMBC and METAvivor represents the very demographic they serve. Dr. Kelly Shanahan, the Board President of METAvivor, has lived with an MBC diagnosis since 2013. Her perspective provides a bridge between clinical reality and the hope for a future where MBC is no longer a death sentence.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research, and it is also a way to bring us together as a community."
Founder Laura Inahara reflects on the growth of the project with a sense of bittersweet pride. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has raised millions for critical research."
The Event: #LightUpMBC Live
The pinnacle of the campaign is the #LightUpMBC Live broadcast, scheduled for October 13 at 8 p.m. ET / 5 p.m. PT. The event is designed to be more than a fundraiser; it is a platform for the voices of those living with the disease.
Hosted by Tami Eagle Bowling—a dedicated advocate who has been living with MBC for over a decade—and Broadway performer/breast cancer survivor Kara Lindsay, the stream will feature a blend of:
- Patient Stories: Personal accounts shared live from the illuminated landmarks themselves.
- Scientific Perspectives: Updates from researchers on the front lines of metastatic discovery.
- Musical Performances: A star-studded lineup including Tony Award winner Victoria Clark, nominee Dorian Harewood, actress Christina Bianco, and singer-songwriter Cassandra Kubinski.
The event will be accessible to a global audience for free via the METAvivor YouTube channel, Facebook Live, and the LiveOne streaming platform.
Implications: The Road Ahead
The implications of the #LightUpMBC movement are twofold: social and medical. Socially, the campaign challenges the public to look beyond the "pink ribbon" narrative and acknowledge the terminal nature of Stage 4 cancer. By bringing the colors of MBC to the most visible structures in the world, the campaign forces a conversation about the necessity of funding research that doesn’t just "detect" cancer, but actively fights to stop it from killing.
Medically, the impact of METAvivor’s funding cannot be overstated. By focusing exclusively on Stage 4, the organization fills a critical gap left by larger, more generalized health charities. As patients live longer, the demand for new treatments that minimize side effects while maximizing lifespan grows.
As the world prepares to turn its lights teal, green, and pink on October 13, the goal remains clear: to move the needle from terminal to manageable. The #LightUpMBC initiative proves that even in the face of a diagnosis that has no cure, there is room for innovation, community, and the persistent, unyielding light of hope.
For those wishing to participate, the call to action is simple: take a photo of an illuminated landmark, share it on social media with the tags #LightUpMBC and #METAvivor, and visit www.lightupmbc.org to contribute to the research that keeps patients like Dr. Kelly Shanahan and Tami Eagle Bowling in the fight for their lives.
About the Author
